This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Aventis Pharma S.a.. Active years: 2002-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2015
Title: The Innovations of Christian Desesquelle
Introduction
Christian Desesquelle is an accomplished inventor based in Soisy-sous-Montmorency, France. He has made significant contributions to the pharmaceutical industry, particularly through his innovative patents. With a total of 2 patents, Desesquelle has focused on developing solid pharmaceutical compositions that enhance drug delivery and efficacy.
Latest Patents
One of his latest patents is a solid pharmaceutical composition comprising telithromycin. This invention relates to a solid pharmaceutical tablet that includes telithromycin or a salt thereof as an active ingredient. The tablet is combined with a plasticizing effective amount of a microcrystalline cellulose diluent that exhibits plastic behavior. Optional ingredients in this formulation may include a binder, a disintegrating agent, and a lubricant. Additionally, the tablet may be optionally coated with a film-coating agent to improve its properties.
Another notable invention by Desesquelle is the pill tablet, which further showcases his expertise in pharmaceutical formulations.
Career Highlights
Christian Desesquelle is currently associated with Aventis Pharma S.A., a leading company in the pharmaceutical sector. His work at Aventis has allowed him to collaborate with other talented professionals in the field, contributing to advancements in drug development.
Collaborations
One of his notable coworkers is Philippe Becourt, with whom he has likely shared insights and expertise in their joint efforts to innovate within the pharmaceutical industry.
Conclusion
Christian Desesquelle's contributions to pharmaceutical innovations, particularly through his patents, highlight his commitment to improving drug formulations. His work continues to impact the industry positively, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
